NCT04306159

Brief Summary

General anesthesia combined subcostal transversus abdominis plane (TAP)or rectus sheath block (RSB)can significantly reduce the use of opiates in minimally invasive surgery.However, similar reduction was not observed in open abdominal surgery during perioperative period.Therefore, the investigators should try to improve the blocking methods to reduce the side effects of a large number of opiates. Based on the range and its analgesic effect of various nerve block is obviously related to the injection site of local anesthetics, this randomized controlled study hypothesized that modified RSB under the guidance of surgical incision may be more effective in inhibiting the harmful stimulation of surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 29, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 12, 2020

Completed
3 days until next milestone

Study Start

First participant enrolled

March 15, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2021

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2021

Completed
Last Updated

August 24, 2021

Status Verified

March 1, 2020

Enrollment Period

1.4 years

First QC Date

February 29, 2020

Last Update Submit

August 22, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Opiate consumption

    Remifentanil consumption

    From the beginning to the end of anesthesia,up to 6 hours.

  • Tumor recurrence rate

    Tumor recurrence rate after surgery

    1-year after surgery

Secondary Outcomes (20)

  • Opiate consumption

    From the end of anesthesia to 48 hours after surgery, up to 2 days.

  • Pain scores

    2 hours after surgery

  • Pain scores

    6 hours after surgery

  • Pain scores

    12 hours after surgery

  • Pain scores

    24 hours after surgery

  • +15 more secondary outcomes

Study Arms (3)

General anesthesia

SHAM COMPARATOR

Basal blood pressure and heart rate were recorded after midazolam administration of 0.02 mg/kg. Anesthesia was induced with sufentanil 0.4 μg/kg and propofol 2-2.5 mg/kg, IV route. An IV bolus of cisatracurium 0.1 mg/kg IV was given to facilitate tracheal intubation. Anesthesia was maintained with propofol 4-6 mg/kg/h combined dexmedetomidine 0.2 μg/kg/h(after 0.2 μg/kg/h loading dose within 15min)by bispectral index (BIS) 40-60 and additional bolus doses of remifentanil 0.2-0.5 μg/kg/min to keep arterial pressure values around 20% below baseline values. Sufentanil 0.1-0.2 μg/kg and flurbiprofen 100mg was administrated once the abdomen was closed, then a patient controlled analgesia pump was used. No RSB was performed.

Other: General anesthesia

Subcostal TAP combined with General anesthesia

EXPERIMENTAL

After induction, TAP was performed. The transversus abdominis plane is imaged with the ultrasound probe obliquely on the upper abdominal wall, along the subcostal margin near the midline.The needle tip was advanced to the desired position where 20 mL 0.375%ropivacaine(Dexamethasone 5mg was added)were injected.The technique is repeated on the opposite side. Anesthesia method and management was same as general anesthesia group.

Procedure: Subcostal TAP

Modified RSB combined with General anesthesia

EXPERIMENTAL

After induction, Modified RSB was performed based on midline incision-guided. The rectus muscle is imaged with the ultrasound probe in a transverse orientation below the xiphisternum and above the umbilicus.The needle tip was advanced to the two desired position where 10 mL ropivacaine 0.375% were injected causing hydrodissection of the rectus muscle away from the posterior rectus sheath.The technique is repeated on the opposite side.Anesthesia method and management was same as general anesthesia group.

Procedure: Modified RSB

Interventions

Subcostal TAPPROCEDURE

Subcostal transversus abdominis plane block

Subcostal TAP combined with General anesthesia
Modified RSBPROCEDURE

Rectus Sheath Block under the guidance of surgical incision

Modified RSB combined with General anesthesia

Traditional general anesthesia management

General anesthesia

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18-85 years
  • Anesthesiologists (ASA) risk classification I to IV
  • Scheduled to undergo midline incision of upper abdomen (From xiphoid to navel )

You may not qualify if:

  • Patient refusal
  • Any contraindications to regional techniques (allergy to local anesthetics, infection around the site of the block, and coagulation disorder)
  • History of analgesics dependence
  • Any difficulty with communication
  • Allergy to the study drugs
  • Heat rate \< 50 beats/minutes or II-III Atrioventricular block
  • Previous open surgery
  • Previous definite history of malignant tumor
  • Who had an estimated intraoperative blood loss of more than 500 mL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Anhui Medical University

Hefei, Anhui, China

Location

MeSH Terms

Interventions

Anesthesia, General

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and Analgesia

Study Officials

  • Guanghong Xu, MD.PHD

    The First Affiliated Hospital of Anhui Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 29, 2020

First Posted

March 12, 2020

Study Start

March 15, 2020

Primary Completion

July 30, 2021

Study Completion

August 16, 2021

Last Updated

August 24, 2021

Record last verified: 2020-03

Locations